copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
DNA for Nucleic Acid-Based Therapies- LineaRx At LineaRx, an Applied DNA Sciences, Inc (NASDAQ: APDN) company, we have a single purpose – to produce therapeutic DNA faster, of higher purity, and with greater scalability than current methods
DNA for Biotherapeutic Applications- LineaRx At LineaRx, an Applied DNA Sciences, Inc (NASDAQ: APDN) company, we have a single purpose – to produce therapeutic DNA faster, of higher purity, and with greater scalability than current methods
LineaRx Stands Ready to Support the Reshoring of Drug Development and . . . LineaRx utilizes its proprietary PCR-based LineaDNA™ platform to rapidly manufacture high-fidelity, cell-free DNA used in the development and manufacture of genetic medicines in quantities ranging from milligram to multi-gram scale
LineaRx Frequently Asked Questions Discover answers to common questions about LineaRx’s synthetic DNA technologies, manufacturing capabilities, GMP standards, and how we support the development of advanced RNA therapeutics
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for . . . STONY BROOK, N Y – June 30, 2025 – Applied DNA Sciences, Inc (NASDAQ: APDN), a leader in PCR-based DNA technologies, announced a strategic restructuring and realignment of resources to focus exclusively on its synthetic DNA manufacturing business, LineaRx
About LineaRx - Plasmid-Based DNA Alternative LineaRx, an Applied DNA Sciences, Inc company (NASDAQ: APDN) delivers enzymatically-produced Linea™ DNA as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies
Leadership Team - LineaRx Our leadership team at LineaRx consists of visionary experts dedicated to advancing innovation and steering the company toward sustainable growth Their leadership empowers our efforts, ensuring that we continue to push the boundaries of DNA-based therapies and make impactful progress in the field of genetic medicine
Applications - LineaRx LineaRx, an Applied DNA Sciences, Inc company, delivers enzymatically-produced LineaDNA™ as an alternative to current plasmid-based DNA manufacturing processes with advantages of speed, purity and scalability to support the next generation of nucleic acid-based therapies